SEC Form 4 · accession 0000950138-16-001280
Keenova Therapeutics plc
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Coleman N Lannum III
Officer — Sr. VP Investor Strategy & IRO · Director
Period of report
Aug 29, 2016
Accepted (ET)
Aug 30, 2016 · 4:15 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001567892
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1,F2 | Aug 29, 2016 | A | 2,359 | $0.00 | A | 22,928 | D | |
| Ordinary Shares | holding | — | — | — | 1,600 | I | By Wife | |
| Ordinary Shares | holding | — | — | — | 75 | I | By son (M) | |
| Ordinary Shares | holding | — | — | — | 45 | I | By son (R) | |
| Ordinary Shares | holding | — | — | — | 45 | I | By son (S) | |
| Ordinary Shares | holding | — | — | — | 20 | I | By mother |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Share Options (Right to Buy)F3 | $74.20 | Aug 29, 2016 | A | 7,020 | A | Aug 29, 2019 | Aug 29, 2026 | Ordinary Shares | 7,020 | 7,020 | D |
Explanation of responses
- F1Represents restricted stock units that vest in their entirety on August 29, 2019.
- F2Includes 13 shares acquired between April 6, 2016 and May 4, 2016 under the Mallinckrodt employee stock purchase plan.
- F3The options vest in their entirety on August 29, 2019.